Trials / Completed
CompletedNCT01950260
Early Levothyroxine Post Radioactive Iodine
Prevention of Overt Hypothyroidism Following Radioactive Iodine Therapy for Graves' Disease
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 61 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The study will try to answer the question of whether early treatment with levothyroxine at 4 weeks after radioactive iodine for Graves'disease will prevent overt hypothyroidism (low thyroid hormone levels).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levothyroxine | Early initiation of levothyroxine after radioactive iodine (to start at 4 weeks). |
| OTHER | Placebo | Placebo to start at 4 weeks after RAI |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2017-04-01
- Completion
- 2017-04-01
- First posted
- 2013-09-25
- Last updated
- 2019-10-29
- Results posted
- 2019-10-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01950260. Inclusion in this directory is not an endorsement.